SKIN — Beauty Health Co Cashflow Statement
0.000.00%
- $124.03m
- $306.17m
- $334.29m
- 78
- 62
- 40
- 62
Annual cashflow statement for Beauty Health Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -29.2 | -375 | 44.4 | -100 | -29.1 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | 9.26 | 348 | -35.5 | 66.3 | 46.9 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -2.58 | -18.7 | -140 | 23.4 | -27.4 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | -12.4 | -28.4 | -107 | 21.8 | 16.1 |
Capital Expenditures | -3.82 | -15.6 | -17.4 | -13 | -6.79 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0 | -22.1 | -1.48 | -18.5 | 0 |
Acquisition of Business | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -3.82 | -37.7 | -18.9 | -31.5 | -6.79 |
Financing Cash Flow Items | -1.3 | 996 | -45.2 | -7.29 | -2.26 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 18.3 | 959 | -205 | -37.4 | -158 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2.18 | 892 | -334 | -45.2 | -153 |